Elexacaftor-tezacaftor-ivacaftor (ETI) may improve bronchial dilatations in adolescents with cystic fibrosis (CF).

New technology is evolving lung cancer detection and treatment at Ascension Sacred Heart Bay in Panama City. It’s called the ...

A new technology is evolving lung cancer detection and treatment at Ascension Sacred Heart Bay. It’s called the ‘Ion ...

ABSTRACT: Background: Anaphylactic shock induced by neuromuscular blocking agents is a rare complication, but it accounts for 50% to 70% of perioperative anaphylactic shocks. Although not yet ...

WASHINGTON (AP) — Lyme disease can cause serious harm, but so can bogus tests and treatments. The complexity of diagnosing the tick-borne disease has given rise to an entire industry of unapproved ...

Childhood cancer treatments can accelerate biological aging, increasing risks for long-term health issues like heart disease and hypertension. Epigenetic age acceleration measures the difference ...

Dr. Zhaoming Wang discussed how childhood cancer treatments can speed up biological aging and impact survivors’ health long after treatment ends. For those diagnosed with cancer at a young age, these ...

PHILADELPHIA--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as an add-on maintenance treatment for adult ...

Nucala is the only approved biologic studied in a wide COPD population with an eosinophilic phenotype characterized by blood eosinophil count (BEC) starting at 150 cells/μL Approval based on the ...

NUCALA is not indicated for the relief of acute bronchospasm. treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). treatment of adult and pediatric patients aged 12 ...